SAINS MEDIKA : JURNAL KEDOKTERAN DAN KESEHATAN
Vol. 16 No. 2 (2025): December 2025

In Silico Docking and ADME-Tox evaluation of annonacin : Addressing contradictions in antimalarial evidence against PfDHODH and PfLDH

Anindya Zerlina Tsaqif (Faculty of Medicine, State University of Malang)
Khodijah Khodijah (Faculty of Medicine, State University of Malang)
Fahrizal Ryuzen Prayogi (Faculty of Mathematics and Science, State University of Malang)
Moh Mirza Nuryady (Biology Education Department, Faculty of Teacher and Training Education, University of Muhammadiyah Malang, Malang, Indonesia)
Kiky Martha Ariesaka (Department of Parasitology, Faculty of Medicine, State University of Malang, Malang, Indonesia)



Article Info

Publish Date
08 Dec 2025

Abstract

The rise of resistance to current antimalarial therapies highlights the urgent need for novel drug candidates.Annona muricata contains phenolic compounds, particularly annonaceous acetogenins, known for theirbioactive properties and cytotoxicity. This study investigates the binding affinity of Annonacin to themalaria target proteins PfDHODH and PfLDH and assesses its toxicity and pharmacokinetic propertiesusing in silico methods. Molecular docking was performed using Molegro Virtual Docker (MVD) version6.0 to explore Annonacin’s binding interactions with PfDHODH and PfLDH. Toxicity was evaluatedusing ProTox-II, focusing on cytotoxicity and LD50 values. Pharmacokinetic parameters, includinggastrointestinal absorption and compliance with Lipinski’s Rule of Five, were analysed using SwissADME.Docking analyses indicated stable complexes of Annonacin with both PfDHODH and PfLDH, suggestingstrong inhibitory potential. Toxicity evaluation revealed significant cytotoxic effects, with an LD50 of400 mg/kg, placing Annonacin in Toxicity Class IV, indicating risk upon ingestion. Pharmacokineticassessments identified challenges, including low gastrointestinal absorption and a violation of Lipinski’srule due to Annonacin’s high molecular weight. Annonacin demonstrates notable antimalarial potential;however, its development is limited by safety issues and pharmacokinetic constraints. Optimisation effortsare essential to enhance efficacy and safety, laying the groundwork for future research and development.

Copyrights © 2025






Journal Info

Abbrev

sainsmedika

Publisher

Subject

Health Professions Medicine & Pharmacology

Description

Sains Medika is journal of medicine and health, is a peer-reviewed and open access journal that focuses on promoting medical sciences generated from Biomedical Sciences, Public Health, Clinical Sciences, and Medical Education to integrate researches in all aspects of human health. This journal ...